Literature DB >> 27032689

A protein and mRNA expression-based classification of gastric cancer.

Namrata Setia1, Agoston T Agoston2, Hye S Han1,3, John T Mullen4, Dan G Duda5, Jeffrey W Clark6, Vikram Deshpande1, Mari Mino-Kenudson1, Amitabh Srivastava2, Jochen K Lennerz1, Theodore S Hong5, Eunice L Kwak6, Gregory Y Lauwers1.   

Abstract

The overall survival of gastric carcinoma patients remains poor despite improved control over known risk factors and surveillance. This highlights the need for new classifications, driven towards identification of potential therapeutic targets. Using sophisticated molecular technologies and analysis, three groups recently provided genetic and epigenetic molecular classifications of gastric cancer (The Cancer Genome Atlas, 'Singapore-Duke' study, and Asian Cancer Research Group). Suggested by these classifications, here, we examined the expression of 14 biomarkers in a cohort of 146 gastric adenocarcinomas and performed unsupervised hierarchical clustering analysis using less expensive and widely available immunohistochemistry and in situ hybridization. Ultimately, we identified five groups of gastric cancers based on Epstein-Barr virus (EBV) positivity, microsatellite instability, aberrant E-cadherin, and p53 expression; the remaining cases constituted a group characterized by normal p53 expression. In addition, the five categories correspond to the reported molecular subgroups by virtue of clinicopathologic features. Furthermore, evaluation between these clusters and survival using the Cox proportional hazards model showed a trend for superior survival in the EBV and microsatellite-instable related adenocarcinomas. In conclusion, we offer as a proposal a simplified algorithm that is able to reproduce the recently proposed molecular subgroups of gastric adenocarcinoma, using immunohistochemical and in situ hybridization techniques.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27032689     DOI: 10.1038/modpathol.2016.55

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  59 in total

1.  Paranuaclear E-cadherin in gastric adenocarcinoma.

Authors:  Philip M Carpenter; Rasha A Al-Kuran; Charles P Theuer
Journal:  Am J Clin Pathol       Date:  2002-12       Impact factor: 2.493

2.  Frequent microsatellite instability in papillary and solid-type, poorly differentiated adenocarcinomas of the stomach.

Authors:  Tomio Arai; Urara Sakurai; Motoji Sawabe; Naoko Honma; Junko Aida; Yasuko Ushio; Nobuo Kanazawa; Kojiro Kuroiwa; Kaiyo Takubo
Journal:  Gastric Cancer       Date:  2012-12-29       Impact factor: 7.370

3.  The role of histological investigation in prognostic evaluation of advanced gastric cancer. Analysis of histological structure and molecular changes compared with invasive pattern and stage.

Authors:  A M Chiaravalli; M Cornaggia; D Furlan; C Capella; R Fiocca; G Tagliabue; C Klersy; E Solcia
Journal:  Virchows Arch       Date:  2001-08       Impact factor: 4.064

4.  Loss of E-cadherin expression in early gastric cancer.

Authors:  P Blok; M E Craanen; W Dekker; G N Tytgat
Journal:  Histopathology       Date:  1999-05       Impact factor: 5.087

5.  Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis.

Authors:  M Constanza Camargo; Woo-Ho Kim; Anna Maria Chiaravalli; Kyoung-Mee Kim; Alejandro H Corvalan; Keitaro Matsuo; Jun Yu; Joseph J Y Sung; Roberto Herrera-Goepfert; Fernando Meneses-Gonzalez; Yuko Kijima; Shoji Natsugoe; Linda M Liao; Jolanta Lissowska; Sung Kim; Nan Hu; Carlos A Gonzalez; Yashushi Yatabe; Chihaya Koriyama; Stephen M Hewitt; Suminori Akiba; Margaret L Gulley; Philip R Taylor; Charles S Rabkin
Journal:  Gut       Date:  2013-04-12       Impact factor: 23.059

6.  Somatic mutations in mismatch repair genes in sporadic gastric carcinomas are not a cause but a consequence of the mutator phenotype.

Authors:  Mafalda Pinto; Ying Wu; Rob G J Mensink; Luís Cirnes; Raquel Seruca; Robert M W Hofstra
Journal:  Cancer Genet Cytogenet       Date:  2008-01-15

7.  Analysis of microsatellite instability, protein expression and methylation status of hMLH1 and hMSH2 genes in gastric carcinomas.

Authors:  Mijin Gu; DongSun Kim; YoungKyung Bae; JoonHyuk Choi; SangWoon Kim; SunKyo Song
Journal:  Hepatogastroenterology       Date:  2009 May-Jun

8.  Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil.

Authors:  Zhengdeng Lei; Iain Beehuat Tan; Kakoli Das; Niantao Deng; Hermioni Zouridis; Sharon Pattison; Clarinda Chua; Zhu Feng; Yeoh Khay Guan; Chia Huey Ooi; Tatiana Ivanova; Shenli Zhang; Minghui Lee; Jeanie Wu; Anna Ngo; Sravanthy Manesh; Elisabeth Tan; Bin Tean Teh; Jimmy Bok Yan So; Liang Kee Goh; Alex Boussioutas; Tony Kiat Hon Lim; Horst Flotow; Patrick Tan; Steven G Rozen
Journal:  Gastroenterology       Date:  2013-05-14       Impact factor: 22.682

9.  Prognostic value of E-cadherin expression in 413 gastric carcinomas.

Authors:  H E Gabbert; W Mueller; A Schneiders; S Meier; R Moll; W Birchmeier; G Hommel
Journal:  Int J Cancer       Date:  1996-06-21       Impact factor: 7.396

Review 10.  Genomic assays for Epstein-Barr virus-positive gastric adenocarcinoma.

Authors:  Margaret L Gulley
Journal:  Exp Mol Med       Date:  2015-01-23       Impact factor: 8.718

View more
  40 in total

1.  Differences in immune contextures among different molecular subtypes of gastric cancer and their prognostic impact.

Authors:  Joo Yeon Kim; Woo Gyeong Kim; Chae Hwa Kwon; Do Youn Park
Journal:  Gastric Cancer       Date:  2019-05-31       Impact factor: 7.370

2.  Loss of ARID1A expression is associated with systemic inflammation markers and has important prognostic significance in gastric cancer.

Authors:  Xuan Wang; Keying Che; Tao Shi; Qin Liu; Xinyun Xu; Hongyan Wu; Lixia Yu; Baorui Liu; Jia Wei
Journal:  J Cancer Res Clin Oncol       Date:  2022-03-16       Impact factor: 4.553

Review 3.  Predictive biomarkers in gastric cancer.

Authors:  C Röcken
Journal:  J Cancer Res Clin Oncol       Date:  2022-10-19       Impact factor: 4.322

4.  Development and Validation of an Easy-to-Implement, Practical Algorithm for the Identification of Molecular Subtypes of Gastric Cancer: Prognostic and Therapeutic Implications.

Authors:  Jiwon Koh; Keun-Wook Lee; Soo Kyung Nam; An Na Seo; Ji-Won Kim; Jin Won Kim; Do Joong Park; Hyung-Ho Kim; Woo Ho Kim; Hye Seung Lee
Journal:  Oncologist       Date:  2019-08-01

5.  Molecular subtyping of gastric cancer with respect to the growth pattern of lymph-node metastases.

Authors:  Florian Bösch; Rumyana Todorova; Helena Link; C Benedikt Westphalen; Stefan Boeck; Volker Heinemann; Jens Werner; Thomas Kirchner; Martin K Angele; Jens Neumann
Journal:  J Cancer Res Clin Oncol       Date:  2019-09-20       Impact factor: 4.553

6.  Scoring systems for PD-L1 expression and their prognostic impact in patients with resectable gastric cancer.

Authors:  Marina Alessandra Pereira; Marcus Fernando Kodama Pertille Ramos; André Roncon Dias; Renan Ribeiro; Leonardo Cardili; Bruno Zilberstein; Ivan Cecconello; Ulysses Ribeiro; Evandro Sobroza de Mello; Tiago Biachi de Castria
Journal:  Virchows Arch       Date:  2020-10-24       Impact factor: 4.064

7.  New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expression.

Authors:  Irene Gullo; Patrícia Oliveira; Maria Athelogou; Gilza Gonçalves; Marta L Pinto; Joana Carvalho; Ana Valente; Hugo Pinheiro; Sara Andrade; Gabriela M Almeida; Ralf Huss; Kakoli Das; Patrick Tan; José C Machado; Carla Oliveira; Fátima Carneiro
Journal:  Gastric Cancer       Date:  2018-05-19       Impact factor: 7.370

8.  Gastric Carcinomas With Lymphoid Stroma: Categorization and Comparison With Solid-Type Colonic Carcinomas.

Authors:  Raul S Gonzalez; Justin M M Cates; Frank Revetta; Loralee A McMahon; Kay Washington
Journal:  Am J Clin Pathol       Date:  2017-11-20       Impact factor: 2.493

9.  Tumor and serum gamma-glutamyl transpeptidase, new prognostic and molecular interpretation of an old biomarker in gastric cancer.

Authors:  Qinchuan Wang; Xiang Shu; Yong Dong; Jichun Zhou; Rongyue Teng; Jianguo Shen; Yongxia Chen; Mingjun Dong; Wenjun Zhang; Yasheng Huang; Shuduo Xie; Qun Wei; Wenhe Zhao; Wenjun Chen; Xiaoming Yuan; Xu Qi; Linbo Wang
Journal:  Oncotarget       Date:  2017-05-30

10.  Clinical Significance of Tumor and Immune Cell PD-L1 Expression in Gastric Adenocarcinoma.

Authors:  Dong Hyun Kim; Go Eun Bae; Kwang Sun Suh; David Ryuman; Kyu Sang Song; Ju Seok Kim; Sang-Il Lee; Min-Kyung Yeo
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.